This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use


Bionow members are welcome to submit PR items to this newsroom for all to see. An animated website user guide is available here which demonstrates how members can add news directly to the website after logging in. 

Whether currently a member or not, to keep in touch with all relevant news and information make sure you are registered to receive our newsletter.


Intertek expands one of Europe’s largest GMP Pharmaceutical stability storage facility

23 May 2017

Intertek, a Total Quality Assurance provider to industries worldwide, today announced the further expansion of its UK GMP (Good Manufacturing Practice) pharmaceutical stability storage facility to a capacity of 250,000 litres. The 10,000 ft² Cambridge facility, one of the largest in Europe, was launched to broaden the range of solutions Intertek can offer to the global pharmaceutical industry, working in tandem with Intertek's Manchester biopharmaceutical laboratory in Blackley, North Manchester.

> Read More


Launch of LJMU Industry Engagement Fund

18 May 2017

Following the successful Life Science Showcase event, LJMU is pleased to announce the launch of their Industry Engagement Fund to encourage collaboration between LJMU academics and industry partners.

> Read More

Sci Tech Daresbury 

Sci-Tech Daresbury named leading UK science park

18 May 2017

Sci-Tech Daresbury has been hailed as the science campus making the most significant contribution to innovation in the UK.

> Read More


A little today, a lot tomorrow - Managing investing risk during turbulent markets

15 March 2017

A common mistake that some investors make is not diversifying their portfolio enough. To make sure investments are spread across different asset classes, it could contain a blend of equities, bonds, cash, property and others (such as commodities and gold) to benefit from their changing investment cycles.

> Read More

Avacta logo small.jpg 

Avacta Group plc announces key Affimer patent to be granted in China

10 May 2017

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and research reagents, is pleased to announce that the principal patent protecting the Affimer technology has been accepted for grant in the People’s Republic of China.

> Read More